4 ms·
Most European countries impose some form of price fixing on pharmaceuticals. The details vary by country but this is often done based on an economic value calcu
by nradov 3y ago
Most European countries impose some form of price fixing on pharmaceuticals. The details vary by country but this is often done based on an economic value calculation, such as the number of quality-adjusted life years (QALYs) that the drug would add for a typical patient. It's not impossible to do this in the USA, at least in the sense that it wouldn't violate the Constitution. But if would somewhat slow down the pace of new drugs. The US pharmaceutical industry launches far more new drugs every year than all of Europe, largely due to the outsize profit potential in the US domestic market. With price fixing we would lose out on some percentage of those new drugs.
- silverquiet 3y agoI have approximately zero interest in new drugs, but better drugs would be great. Is that the case? My impression is that the latest two blockbuster drugs that I’m aware of - mRNA vaccines and GLP1 agonists, had substantial European development, such that Novo-Nordisk is substantially impacting the GDP of Norway today.
- justinclift 3y ago> Norway Denmark, not Norway. Novo Nordisk's market capitalization exceeded the GDP of Denmark's domestic economy in 2023, and it is the highest valued pharmaceutical company in Europe. https://en.wikipedia.org/wiki/Novo_Nordisk https://en.wikipedia.org/wiki/Novo_Nordisk
- deleted 3y ago[deleted]